Malignant pericardial effusion complicated by cardiac tamponade under atezolizumab

Immune-related adverse events including cardiac toxicity are increasingly described in patients receiving immune checkpoint inhibitors. We described a malignant pericardial effusion complicated by a cardiac tamponade in an advanced non-small cell lung cancer patient who had received five infusions o...

Descripción completa

Detalles Bibliográficos
Autores principales: Benjamin, Lardinois, Jean-Charles, Goeminne, Laurence, Miller, Adrien, Randazzo, Terry, Laurent, Régis, Debois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323422/
https://www.ncbi.nlm.nih.gov/pubmed/34377486
http://dx.doi.org/10.1177/2050313X211036005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323422/
https://www.ncbi.nlm.nih.gov/pubmed/34377486
http://dx.doi.org/10.1177/2050313X211036005

Ejemplares similares